CIK 0000109657 · Non-accelerated filer<br>Smaller reporting company
GT Biopharma, Inc.
Sign in to watch- Ticker
- GTBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 941620407
- Phone
- (800) 304-9888
- Business address
- 505 MONTGOMERY STREET, 10TH FLOOR, SAN FRANCISCO, CA, 94111
- Former names
- GT Biopharma, Inc., OXIS INTERNATIONAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 14 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2004-10-12 | HAUSMAN MARVIN S MD Director | Grant or award · stock option (right to buy) | +50,000 | $0.59 | $30K | 85,000 |
| 2004-10-12 | BRUINSMA GOSSE B Chairman, Acting CEO | Grant or award · stock option (right to buy) | +100,000 | $0.59 | $59K | 135,000 |
| 2004-10-12 | FERRIS STEVEN H Director | Grant or award · stock option (right to buy) | +50,000 | $0.59 | $30K | 85,000 |
| 2004-10-12 | NEILL SYDNEY COLIN Director | Grant or award · stock option (right to buy) | +100,000 | $0.59 | $59K | 135,000 |
| 2004-10-12 | VLAK GERARD J M Director | Grant or award · stock option (right to buy) | +50,000 | $0.59 | $30K | 85,000 |
| 2004-10-12 | RODELL TIMOTHY C JR Director | Grant or award · stock option (right to buy) | −50,000 | $0.59 | $30K | 350,237 |
| 2004-06-22 | DAVIS RICHARD A Director | Grant or award · Stock Option (right to buy) | −5,000 | $0.57 | $3K | 107,147 |
| 2004-06-22 | RODELL TIMOTHY C JR Director | Grant or award · Stock Option (right to buy) | +5,000 | $0.57 | $3K | 301,327 |
| 2004-06-22 | RODELL TIMOTHY C JR Director | Grant or award · Stock Option (right to buy) | +15,000 | $0.57 | $9K | 311,237 |
| 2004-06-22 | DAVIS RICHARD A Director | Grant or award · Stock Option (right to buy) | +15,000 | $0.57 | $9K | 117,147 |
| 2004-04-26 | NEILL SYDNEY COLIN Director | Grant or award · Common Stock | +30,000 | $0.69 | $21K | 30,000 |
| 2004-04-26 | FERRIS STEVEN H Director | Grant or award · Common Stock | +30,000 | $0.69 | $21K | 30,000 |
| 2004-04-26 | BRUINSMA GOSSE B Director | Grant or award · Common Stock | +30,000 | $0.69 | $21K | 30,000 |
| 2004-04-26 | VLAK GERARD J M Director | Grant or award · Common Stock | +30,000 | $0.69 | $21K | 30,000 |
| 2004-04-26 | BRUINSMA GOSSE B Director | Grant or award · Common Stock | −30,000 | $0.69 | $21K | 30,000 |
| 2004-04-26 | FERRIS STEVEN H Director | Grant or award · Common Stock | −35,000 | $0.69 | $24K | 30,000 |
| 2004-04-26 | NEILL SYDNEY COLIN Director | Grant or award · CommonStock | −30,000 | $0.69 | $21K | 30,000 |
| 2003-12-04 | ELLIS SHARON Chief Operational & Financial | Grant or award · Stock Option (right to buy) | +150,000 | $0.56 | $84K | 885,000 |
| 2003-12-04 | ROGERS RAY R CEO/Chairman of the Board | Grant or award · Stock Option (right to buy) | +150,000 | $0.56 | $84K | 1,827,988 |
| 2003-12-04 | ROGERS RAY R CEO/Chairman of the Board | Gift | −10,000 | $0.48 | $5K | 1,677,988 |
Page 8 of 9 · 164 trades